Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis
Pengbo Yu, Yinan Wang, Fengbo Su, Yan Chen · 2024
Read Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis by Pengbo Yu, Yinan Wang, Fengbo Su, Yan Chen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10805829.txt.
Description
Pengbo Yu and co-authors pool the evidence on two PET tracers for telling a returned brain tumor from treatment scars. Gliomas that seem gone can regrow, and scan choices shape what happens next. The meta-analysis gathered twenty-two studies covering over fifteen hundred patients scanned with either FET or FDOPA, two amino-acid tracers that light up tumor tissue.
FET caught about eighty-four percent of recurrences and cleared about eighty-six percent of non-recurrences. FDOPA ran higher on both counts, at roughly ninety-five and ninety percent. The sensitivity gap between the tracers reached statistical significance, while the specificity gap did not. The authors read FDOPA as the sharper recurrence hunter where it is available, with FET a close and more common stand-in.
Catalog record
| CREATOR | Pengbo Yu, Yinan Wang, Fengbo Su, Yan Chen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |